Skip to main content
Amphastar Pharmaceuticals, Inc. logo

Amphastar Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · AMPH ISIN · US03209R1032 LEI · 54930055TH0ZLSAQMJ38 US Manufacturing
Filings indexed 913 across all filing types
Latest filing 2025-12-11 Regulatory Filings
Country US United States of America
Listing US AMPH

About Amphastar Pharmaceuticals, Inc.

https://amphastar.com/

Amphastar Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing, manufacturing, and marketing technically challenging medications. Its portfolio includes generic and proprietary injectable, intranasal, and inhalation products. The company specializes in complex medications such as biologics derived from living cells, proteins, and interchangeable biosimilars. Amphastar also develops innovative drug delivery systems and proprietary technological platforms for various routes of administration.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2025
Regulatory Filings
2025-12-11 English
Regulatory Filings 2025
Regulatory Filings
2025-12-10 English
Piper Sandler Presentation
Investor Presentation Classification · 1% confidence The document is a slide deck presentation titled 'Piper Sandler 37th Annual Healthcare Conference' for Amphastar Pharmaceuticals. It contains detailed information on company strategy, R&D pipelines, financial performance metrics, and product development plans. It is clearly intended for an investor audience to communicate the company's market position and future growth prospects. This fits the definition of an Investor Presentation.
2025-12-03 English
Regulatory Filings 2025
Regulatory Filings
2025-11-28 English
Director's Dealing 2025
Director's Dealing
2025-11-26 English
Regulatory Filings 2025
Regulatory Filings
2025-11-25 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.